Report Overview:
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
The Global Precision Cancer Diagnostic Tests Market Size was estimated at USD 4829.57 million in 2023 and is projected to reach USD 9790.92 million by 2029, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Precision Cancer Diagnostic Tests market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Precision Cancer Diagnostic Tests Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Precision Cancer Diagnostic Tests market in any manner.
Global Precision Cancer Diagnostic Tests Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
Market Segmentation (by Type)
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Precision Cancer Diagnostic Tests Market
? Overview of the regional outlook of the Precision Cancer Diagnostic Tests Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Diagnostic Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Precision Cancer Diagnostic Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Precision Cancer Diagnostic Tests Market Competitive Landscape
3.1 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Precision Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Precision Cancer Diagnostic Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Precision Cancer Diagnostic Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2019-2024)
7 Precision Cancer Diagnostic Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 Precision Cancer Diagnostic Tests Market Segmentation by Region
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Precision Cancer Diagnostic Tests Basic Information
9.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
9.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Precision Cancer Diagnostic Tests SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Precision Cancer Diagnostic Tests Basic Information
9.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
9.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Precision Cancer Diagnostic Tests SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Becton Dickinson and Company
9.3.1 Becton Dickinson and Company Precision Cancer Diagnostic Tests Basic Information
9.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
9.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
9.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests SWOT Analysis
9.3.5 Becton Dickinson and Company Business Overview
9.3.6 Becton Dickinson and Company Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Basic Information
9.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
9.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Biocartis N.V.
9.5.1 Biocartis N.V. Precision Cancer Diagnostic Tests Basic Information
9.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
9.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.5.4 Biocartis N.V. Business Overview
9.5.5 Biocartis N.V. Recent Developments
9.6 Biocept
9.6.1 Biocept Precision Cancer Diagnostic Tests Basic Information
9.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
9.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
9.6.4 Biocept Business Overview
9.6.5 Biocept Recent Developments
9.7 bioMerieux SA
9.7.1 bioMerieux SA Precision Cancer Diagnostic Tests Basic Information
9.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
9.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
9.7.4 bioMerieux SA Business Overview
9.7.5 bioMerieux SA Recent Developments
9.8 Canon Medical Systems Corporation
9.8.1 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Basic Information
9.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
9.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.8.4 Canon Medical Systems Corporation Business Overview
9.8.5 Canon Medical Systems Corporation Recent Developments
9.9 Cynvenio Biosystems
9.9.1 Cynvenio Biosystems Precision Cancer Diagnostic Tests Basic Information
9.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
9.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
9.9.4 Cynvenio Biosystems Business Overview
9.9.5 Cynvenio Biosystems Recent Developments
9.10 Danaher Corporation
9.10.1 Danaher Corporation Precision Cancer Diagnostic Tests Basic Information
9.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
9.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.10.4 Danaher Corporation Business Overview
9.10.5 Danaher Corporation Recent Developments
9.11 Epigenomics AG
9.11.1 Epigenomics AG Precision Cancer Diagnostic Tests Basic Information
9.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
9.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
9.11.4 Epigenomics AG Business Overview
9.11.5 Epigenomics AG Recent Developments
9.12 Exosome Diagnostics
9.12.1 Exosome Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.12.4 Exosome Diagnostics Business Overview
9.12.5 Exosome Diagnostics Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Precision Cancer Diagnostic Tests Basic Information
9.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
9.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
9.14 General Electric Company
9.14.1 General Electric Company Precision Cancer Diagnostic Tests Basic Information
9.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
9.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
9.14.4 General Electric Company Business Overview
9.14.5 General Electric Company Recent Developments
9.15 Genomic Health
9.15.1 Genomic Health Precision Cancer Diagnostic Tests Basic Information
9.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
9.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
9.15.4 Genomic Health Business Overview
9.15.5 Genomic Health Recent Developments
9.16 Hologic
9.16.1 Hologic Precision Cancer Diagnostic Tests Basic Information
9.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
9.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
9.16.4 Hologic Business Overview
9.16.5 Hologic Recent Developments
9.17 Illumina
9.17.1 Illumina Precision Cancer Diagnostic Tests Basic Information
9.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
9.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
9.17.4 Illumina Business Overview
9.17.5 Illumina Recent Developments
9.18 Menarini Silicon Biosystems SpA
9.18.1 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Basic Information
9.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
9.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
9.18.4 Menarini Silicon Biosystems SpA Business Overview
9.18.5 Menarini Silicon Biosystems SpA Recent Developments
9.19 Myriad Genetics
9.19.1 Myriad Genetics Precision Cancer Diagnostic Tests Basic Information
9.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
9.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
9.19.4 Myriad Genetics Business Overview
9.19.5 Myriad Genetics Recent Developments
9.20 NanoString Technologies
9.20.1 NanoString Technologies Precision Cancer Diagnostic Tests Basic Information
9.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
9.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.20.4 NanoString Technologies Business Overview
9.20.5 NanoString Technologies Recent Developments
9.21 Ortho Clinical Diagnostics
9.21.1 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.21.4 Ortho Clinical Diagnostics Business Overview
9.21.5 Ortho Clinical Diagnostics Recent Developments
9.22 QIAGEN N.V.
9.22.1 QIAGEN N.V. Precision Cancer Diagnostic Tests Basic Information
9.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
9.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.22.4 QIAGEN N.V. Business Overview
9.22.5 QIAGEN N.V. Recent Developments
9.23 Randox Laboratories Ltd.
9.23.1 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Basic Information
9.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
9.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
9.23.4 Randox Laboratories Ltd. Business Overview
9.23.5 Randox Laboratories Ltd. Recent Developments
9.24 Roche Holding AG
9.24.1 Roche Holding AG Precision Cancer Diagnostic Tests Basic Information
9.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
9.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
9.24.4 Roche Holding AG Business Overview
9.24.5 Roche Holding AG Recent Developments
9.25 Royal Philips N.V.
9.25.1 Royal Philips N.V. Precision Cancer Diagnostic Tests Basic Information
9.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
9.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.25.4 Royal Philips N.V. Business Overview
9.25.5 Royal Philips N.V. Recent Developments
9.26 Siemens AG
9.26.1 Siemens AG Precision Cancer Diagnostic Tests Basic Information
9.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
9.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
9.26.4 Siemens AG Business Overview
9.26.5 Siemens AG Recent Developments
9.27 Thermo Fisher Scientific
9.27.1 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Basic Information
9.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
9.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
9.27.4 Thermo Fisher Scientific Business Overview
9.27.5 Thermo Fisher Scientific Recent Developments
9.28 Vela Diagnostics
9.28.1 Vela Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.28.4 Vela Diagnostics Business Overview
9.28.5 Vela Diagnostics Recent Developments
10 Precision Cancer Diagnostic Tests Market Forecast by Region
10.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
10.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Precision Cancer Diagnostic Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Precision Cancer Diagnostic Tests Market Size Comparison by Region (M USD)
Table 5. Global Precision Cancer Diagnostic Tests Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Precision Cancer Diagnostic Tests Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Precision Cancer Diagnostic Tests Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2022)
Table 10. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Precision Cancer Diagnostic Tests Sales Sites and Area Served
Table 12. Manufacturers Precision Cancer Diagnostic Tests Product Type
Table 13. Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Precision Cancer Diagnostic Tests
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Precision Cancer Diagnostic Tests Market Challenges
Table 22. Global Precision Cancer Diagnostic Tests Sales by Type (K Units)
Table 23. Global Precision Cancer Diagnostic Tests Market Size by Type (M USD)
Table 24. Global Precision Cancer Diagnostic Tests Sales (K Units) by Type (2019-2024)
Table 25. Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
Table 26. Global Precision Cancer Diagnostic Tests Market Size (M USD) by Type (2019-2024)
Table 27. Global Precision Cancer Diagnostic Tests Market Size Share by Type (2019-2024)
Table 28. Global Precision Cancer Diagnostic Tests Price (USD/Unit) by Type (2019-2024)
Table 29. Global Precision Cancer Diagnostic Tests Sales (K Units) by Application
Table 30. Global Precision Cancer Diagnostic Tests Market Size by Application
Table 31. Global Precision Cancer Diagnostic Tests Sales by Application (2019-2024) & (K Units)
Table 32. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Table 33. Global Precision Cancer Diagnostic Tests Sales by Application (2019-2024) & (M USD)
Table 34. Global Precision Cancer Diagnostic Tests Market Share by Application (2019-2024)
Table 35. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Table 36. Global Precision Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 37. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Table 38. North America Precision Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 39. Europe Precision Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Precision Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 41. South America Precision Cancer Diagnostic Tests Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Precision Cancer Diagnostic Tests Basic Information
Table 44. Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 45. Abbott Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Precision Cancer Diagnostic Tests SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Agilent Technologies Precision Cancer Diagnostic Tests Basic Information
Table 50. Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
Table 51. Agilent Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Precision Cancer Diagnostic Tests SWOT Analysis
Table 54. Agilent Technologies Recent Developments
Table 55. Becton Dickinson and Company Precision Cancer Diagnostic Tests Basic Information
Table 56. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
Table 57. Becton Dickinson and Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Becton Dickinson and Company Precision Cancer Diagnostic Tests SWOT Analysis
Table 59. Becton Dickinson and Company Business Overview
Table 60. Becton Dickinson and Company Recent Developments
Table 61. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Basic Information
Table 62. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
Table 63. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bio-Rad Laboratories Business Overview
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Biocartis N.V. Precision Cancer Diagnostic Tests Basic Information
Table 67. Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
Table 68. Biocartis N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Biocartis N.V. Business Overview
Table 70. Biocartis N.V. Recent Developments
Table 71. Biocept Precision Cancer Diagnostic Tests Basic Information
Table 72. Biocept Precision Cancer Diagnostic Tests Product Overview
Table 73. Biocept Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Biocept Business Overview
Table 75. Biocept Recent Developments
Table 76. bioMerieux SA Precision Cancer Diagnostic Tests Basic Information
Table 77. bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
Table 78. bioMerieux SA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. bioMerieux SA Business Overview
Table 80. bioMerieux SA Recent Developments
Table 81. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Basic Information
Table 82. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
Table 83. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Canon Medical Systems Corporation Business Overview
Table 85. Canon Medical Systems Corporation Recent Developments
Table 86. Cynvenio Biosystems Precision Cancer Diagnostic Tests Basic Information
Table 87. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
Table 88. Cynvenio Biosystems Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cynvenio Biosystems Business Overview
Table 90. Cynvenio Biosystems Recent Developments
Table 91. Danaher Corporation Precision Cancer Diagnostic Tests Basic Information
Table 92. Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
Table 93. Danaher Corporation Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Danaher Corporation Business Overview
Table 95. Danaher Corporation Recent Developments
Table 96. Epigenomics AG Precision Cancer Diagnostic Tests Basic Information
Table 97. Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
Table 98. Epigenomics AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Epigenomics AG Business Overview
Table 100. Epigenomics AG Recent Developments
Table 101. Exosome Diagnostics Precision Cancer Diagnostic Tests Basic Information
Table 102. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 103. Exosome Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Exosome Diagnostics Business Overview
Table 105. Exosome Diagnostics Recent Developments
Table 106. Foundation Medicine Precision Cancer Diagnostic Tests Basic Information
Table 107. Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
Table 108. Foundation Medicine Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Foundation Medicine Business Overview
Table 110. Foundation Medicine Recent Developments
Table 111. General Electric Company Precision Cancer Diagnostic Tests Basic Information
Table 112. General Electric Company Precision Cancer Diagnostic Tests Product Overview
Table 113. General Electric Company Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. General Electric Company Business Overview
Table 115. General Electric Company Recent Developments
Table 116. Genomic Health Precision Cancer Diagnostic Tests Basic Information
Table 117. Genomic Health Precision Cancer Diagnostic Tests Product Overview
Table 118. Genomic Health Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Genomic Health Business Overview
Table 120. Genomic Health Recent Developments
Table 121. Hologic Precision Cancer Diagnostic Tests Basic Information
Table 122. Hologic Precision Cancer Diagnostic Tests Product Overview
Table 123. Hologic Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Hologic Business Overview
Table 125. Hologic Recent Developments
Table 126. Illumina Precision Cancer Diagnostic Tests Basic Information
Table 127. Illumina Precision Cancer Diagnostic Tests Product Overview
Table 128. Illumina Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Illumina Business Overview
Table 130. Illumina Recent Developments
Table 131. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Basic Information
Table 132. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
Table 133. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Menarini Silicon Biosystems SpA Business Overview
Table 135. Menarini Silicon Biosystems SpA Recent Developments
Table 136. Myriad Genetics Precision Cancer Diagnostic Tests Basic Information
Table 137. Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
Table 138. Myriad Genetics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Myriad Genetics Business Overview
Table 140. Myriad Genetics Recent Developments
Table 141. NanoString Technologies Precision Cancer Diagnostic Tests Basic Information
Table 142. NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
Table 143. NanoString Technologies Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. NanoString Technologies Business Overview
Table 145. NanoString Technologies Recent Developments
Table 146. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Basic Information
Table 147. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 148. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Ortho Clinical Diagnostics Business Overview
Table 150. Ortho Clinical Diagnostics Recent Developments
Table 151. QIAGEN N.V. Precision Cancer Diagnostic Tests Basic Information
Table 152. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
Table 153. QIAGEN N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. QIAGEN N.V. Business Overview
Table 155. QIAGEN N.V. Recent Developments
Table 156. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Basic Information
Table 157. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
Table 158. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Randox Laboratories Ltd. Business Overview
Table 160. Randox Laboratories Ltd. Recent Developments
Table 161. Roche Holding AG Precision Cancer Diagnostic Tests Basic Information
Table 162. Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
Table 163. Roche Holding AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Roche Holding AG Business Overview
Table 165. Roche Holding AG Recent Developments
Table 166. Royal Philips N.V. Precision Cancer Diagnostic Tests Basic Information
Table 167. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
Table 168. Royal Philips N.V. Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Royal Philips N.V. Business Overview
Table 170. Royal Philips N.V. Recent Developments
Table 171. Siemens AG Precision Cancer Diagnostic Tests Basic Information
Table 172. Siemens AG Precision Cancer Diagnostic Tests Product Overview
Table 173. Siemens AG Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Siemens AG Business Overview
Table 175. Siemens AG Recent Developments
Table 176. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Basic Information
Table 177. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
Table 178. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Thermo Fisher Scientific Business Overview
Table 180. Thermo Fisher Scientific Recent Developments
Table 181. Vela Diagnostics Precision Cancer Diagnostic Tests Basic Information
Table 182. Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
Table 183. Vela Diagnostics Precision Cancer Diagnostic Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Vela Diagnostics Business Overview
Table 185. Vela Diagnostics Recent Developments
Table 186. Global Precision Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 187. Global Precision Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 188. North America Precision Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 189. North America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 190. Europe Precision Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 191. Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 192. Asia Pacific Precision Cancer Diagnostic Tests Sales Forecast by Region (2025-2030) & (K Units)
Table 193. Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region (2025-2030) & (M USD)
Table 194. South America Precision Cancer Diagnostic Tests Sales Forecast by Country (2025-2030) & (K Units)
Table 195. South America Precision Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 196. Middle East and Africa Precision Cancer Diagnostic Tests Consumption Forecast by Country (2025-2030) & (Units)
Table 197. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Forecast by Country (2025-2030) & (M USD)
Table 198. Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2025-2030) & (K Units)
Table 199. Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030) & (M USD)
Table 200. Global Precision Cancer Diagnostic Tests Price Forecast by Type (2025-2030) & (USD/Unit)
Table 201. Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application (2025-2030)
Table 202. Global Precision Cancer Diagnostic Tests Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Precision Cancer Diagnostic Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Cancer Diagnostic Tests Market Size (M USD), 2019-2030
Figure 5. Global Precision Cancer Diagnostic Tests Market Size (M USD) (2019-2030)
Figure 6. Global Precision Cancer Diagnostic Tests Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Cancer Diagnostic Tests Market Size by Country (M USD)
Figure 11. Precision Cancer Diagnostic Tests Sales Share by Manufacturers in 2023
Figure 12. Global Precision Cancer Diagnostic Tests Revenue Share by Manufacturers in 2023
Figure 13. Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Precision Cancer Diagnostic Tests Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Precision Cancer Diagnostic Tests Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Precision Cancer Diagnostic Tests Market Share by Type
Figure 18. Sales Market Share of Precision Cancer Diagnostic Tests by Type (2019-2024)
Figure 19. Sales Market Share of Precision Cancer Diagnostic Tests by Type in 2023
Figure 20. Market Size Share of Precision Cancer Diagnostic Tests by Type (2019-2024)
Figure 21. Market Size Market Share of Precision Cancer Diagnostic Tests by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Precision Cancer Diagnostic Tests Market Share by Application
Figure 24. Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2019-2024)
Figure 25. Global Precision Cancer Diagnostic Tests Sales Market Share by Application in 2023
Figure 26. Global Precision Cancer Diagnostic Tests Market Share by Application (2019-2024)
Figure 27. Global Precision Cancer Diagnostic Tests Market Share by Application in 2023
Figure 28. Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
Figure 29. Global Precision Cancer Diagnostic Tests Sales Market Share by Region (2019-2024)
Figure 30. North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 32. U.S. Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Precision Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Precision Cancer Diagnostic Tests Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Precision Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 37. Germany Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Precision Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 44. China Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 50. South America Precision Cancer Diagnostic Tests Sales Market Share by Country in 2023
Figure 51. Brazil Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Precision Cancer Diagnostic Tests Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Precision Cancer Diagnostic Tests Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Precision Cancer Diagnostic Tests Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Precision Cancer Diagnostic Tests Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2025-2030)
Figure 65. Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2025-2030)
Figure 66. Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2025-2030)
